Research ArticleResearch
Comparison of Different Calculation Approaches for Defining Microbiological Control Levels Based on Historical Data
Oliver Gordon, Marcel Goverde, James Pazdan, Alexandra Staerk and David Roesti
PDA Journal of Pharmaceutical Science and Technology May 2015, 69 (3) 383-398; DOI: https://doi.org/10.5731/pdajpst.2015.01050
Oliver Gordon
1Immunobiology Laboratory, Cancer Research UK London Research Institute, London UK;
Marcel Goverde
3MGP Consulting GmbH, Binningen, Switzerland; and
James Pazdan
4Pharma Development, Novartis Pharmaceuticals Corporation, Hanover, NJ, USA
Alexandra Staerk
2Microbiological Quality Control Unit, Novartis Pharma Stein AG, Stein, Switzerland;
David Roesti
2Microbiological Quality Control Unit, Novartis Pharma Stein AG, Stein, Switzerland;
References
- 1.↵European Medicines Agency. EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use, Annex 1: Manufacture of Sterile Medicinal Products, 2009.
- 2.↵Food and Drug Administration. Sterile Drug Products Produced by Aseptic Processing. Guidance for Industry, Pharmaceutical CGMPs, 2004.
- 3.↵Chapter 5.1.4. Microbiological Quality of Non-Sterile Pharmaceutical Preparations and Substances for Pharmaceutical Use. In European Pharmacopoeia, 8th ed.; 2014.
- 4.↵Chapter <1111> Microbiological Examination of Nonsterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use. In United States Pharmacopeia 37—National Formulary 32; 2014.
- 5.↵
- Jimenez L.
- Jimenez L.
- 6.↵ICH Q10 Pharmaceutical Quality System. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2011.
- 7.↵PDA Technical Report No. 13. Fundamentals of an Environmental Monitoring Program. PDA J. Pharm. Sci. Technol. 2001, 55 (5 Suppl.), 1–35.
- 8.↵
- Cholayudth P.
- 9.↵
- Wilson J. D.
- 10.↵
- Hussong D.,
- Madsen R. E.
- 11.
- Yang H.,
- Zhao W.,
- O'day T.,
- Fleming W.
- 12.↵
- Moldenhauer J.
- Rozo M.
- 13.↵
- Poisson S. D.
- 14.↵
- Fisher R. A.,
- Thorton H. G.,
- Mackenzie W. A.
- 15.↵
- Agresti A.
- 16.↵
- Greene W. H.
- 17.
- Shapiro S. S.,
- Wilk M. B.
- 18.↵e-Handbook of Statistical Methods. NIST/SEMATECH, 2014 (online). Available at: http://www.itl.nist.gov/div898/handbook/prc/section2/prc252.htm (accessed May 9, 2014).
- 19.↵
- Caputo R. A.,
- Huffmann A.
- 20.↵Chapter <1116> Microbiological Control and Monitoring of Aseptic Processing Environments. In United States Pharmacopeia 37—National Formulary 32, 2014.
- 21.↵
- Pfohl M.,
- Fricker P.,
- Kohler D.,
- Berchtold M.
- 22.↵
- Pfohl M.,
- Fricker P.,
- Kohler D.,
- Berchtold M.
- 23.↵
- Amann R. I.,
- Ludwig W.,
- Schleifer K. H.
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 69, Issue 3
May/June 2015
Comparison of Different Calculation Approaches for Defining Microbiological Control Levels Based on Historical Data
Oliver Gordon, Marcel Goverde, James Pazdan, Alexandra Staerk, David Roesti
PDA Journal of Pharmaceutical Science and Technology May 2015, 69 (3) 383-398; DOI: 10.5731/pdajpst.2015.01050
Comparison of Different Calculation Approaches for Defining Microbiological Control Levels Based on Historical Data
Oliver Gordon, Marcel Goverde, James Pazdan, Alexandra Staerk, David Roesti
PDA Journal of Pharmaceutical Science and Technology May 2015, 69 (3) 383-398; DOI: 10.5731/pdajpst.2015.01050
Jump to section
Related Articles
- No related articles found.